172 related articles for article (PubMed ID: 19845581)
1. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies.
El-Zoghby ZM; Grande JP; Fraile MG; Norby SM; Fervenza FC; Cosio FG
Am J Transplant; 2009 Dec; 9(12):2800-7. PubMed ID: 19845581
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL
Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
4. The pathology and clinical features of early recurrent membranous glomerulonephritis.
Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD
Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329
[TBL] [Abstract][Full Text] [Related]
5. Rituximab treatment of idiopathic membranous nephropathy.
Fervenza FC; Cosio FG; Erickson SB; Specks U; Herzenberg AM; Dillon JJ; Leung N; Cohen IM; Wochos DN; Bergstralh E; Hladunewich M; Cattran DC
Kidney Int; 2008 Jan; 73(1):117-25. PubMed ID: 17943078
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.
Boyer-Suavet S; Andreani M; Lateb M; Savenkoff B; Brglez V; Benzaken S; Bernard G; Nachman PH; Esnault V; Seitz-Polski B
Front Immunol; 2019; 10():3069. PubMed ID: 31998325
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient.
Gallon L; Chhabra D
Am J Transplant; 2006 Dec; 6(12):3017-21. PubMed ID: 17294527
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
Ishiwatari A; Wakai S; Shirakawa H; Honda K
Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
[TBL] [Abstract][Full Text] [Related]
9. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study.
Dabade TS; Grande JP; Norby SM; Fervenza FC; Cosio FG
Am J Transplant; 2008 Jun; 8(6):1318-22. PubMed ID: 18444918
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
11. Single-dose rituximab for recurrent glomerulonephritis post-renal transplant.
Spinner ML; Bowman LJ; Horwedel TA; Delos Santos RB; Klein CL; Brennan DC
Am J Nephrol; 2015; 41(1):37-47. PubMed ID: 25634230
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy.
Barbari A; Chehadi R; Kfoury Assouf H; Kamel G; Jaafar M; Abdallah A; Rizk S; Masri M
Exp Clin Transplant; 2017 Jun; 15(3):350-354. PubMed ID: 28367758
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy for membranous nephropathy: a systematic review.
Bomback AS; Derebail VK; McGregor JG; Kshirsagar AV; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2009 Apr; 4(4):734-44. PubMed ID: 19279120
[TBL] [Abstract][Full Text] [Related]
14. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies.
Buxeda A; Said SM; Nasr SH; Leung N; El Ters M; Cosio FG
Transplantation; 2019 Jul; 103(7):1477-1485. PubMed ID: 30747850
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study.
Hullekes F; Uffing A; Verhoeff R; Seeger H; von Moos S; Mansur J; Mastroianni-Kirsztajn G; Silva HT; Buxeda A; Pérez-Sáez MJ; Arias-Cabrales C; Collins AB; Swett C; Morená L; Loucaidou M; Kousios A; Malvezzi P; Bugnazet M; Russo LS; Muhsin SA; Agrawal N; Nissaisorakarn P; Patel H; Al Jurdi A; Akalin E; Neto ED; Agena F; Ventura C; Manfro RC; Bauer AC; Mazzali M; de Sousa MV; La Manna G; Bini C; Comai G; Reindl-Schwaighofer R; Berger S; Cravedi P; Riella LV
Am J Transplant; 2024 Jun; 24(6):1016-1026. PubMed ID: 38341027
[TBL] [Abstract][Full Text] [Related]
18. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
[TBL] [Abstract][Full Text] [Related]
19. [Membranous nephropathy].
Yokoyama H; Yoshimoto K; Wada T
Nihon Rinsho; 2004 Oct; 62(10):1856-60. PubMed ID: 15500130
[TBL] [Abstract][Full Text] [Related]
20. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.
Beck LH; Fervenza FC; Beck DM; Bonegio RG; Malik FA; Erickson SB; Cosio FG; Cattran DC; Salant DJ
J Am Soc Nephrol; 2011 Aug; 22(8):1543-50. PubMed ID: 21784898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
